Published in Oncol Lett on May 28, 2014
An acetone-based phantom for quantitative diffusion MRI. J Magn Reson Imaging (2017) 0.75
Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med (2000) 3.34
Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology (2002) 2.95
Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology (2005) 2.18
Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging (2000) 2.06
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol (2009) 1.70
Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology (1998) 1.33
Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol (2003) 1.31
Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel. Proc Natl Acad Sci U S A (1982) 1.29
Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol (2010) 1.23
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res (2008) 1.17
Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR. Magn Reson Med (1997) 1.17
Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging (2011) 1.13
Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging (2011) 1.04
Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging. J Magn Reson Imaging (2012) 1.04
Quantification of water compartmentation in cell suspensions by diffusion-weighted and T(2)-weighted MRI. Magn Reson Imaging (2007) 0.95
Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²). J Magn Reson Imaging (2012) 0.91
Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck. Acta Radiol (2008) 0.89
A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging. Int J Oncol (2009) 0.86
Correlation of apparent diffusion coefficient at 3T with prognostic parameters of retinoblastoma. AJNR Am J Neuroradiol (2012) 0.85
Initial experience of 3 tesla apparent diffusion coefficient values in differentiating benign and malignant thyroid nodules. J Magn Reson Imaging (2012) 0.85
High b-value diffusion-weighted MR imaging of normal brain at 3T. Eur J Radiol (2007) 0.83
Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results. Abdom Imaging (2012) 0.82
Visualization of ovarian tumors using 3T MR imaging: diagnostic effectiveness and difficulties. Magn Reson Med Sci (2012) 0.79
[Investigation of a phantom for diffusion weighted imaging that controlled the apparent diffusion coefficient using gelatin and sucrose]. Nihon Hoshasen Gijutsu Gakkai Zasshi (2009) 0.78
In vitro assessment of factors affecting the apparent diffusion coefficient of Ramos cells using bio-phantoms. Acta Med Okayama (2012) 0.77